Schedule of Pharmaceutical Benefits - 1 June 2017

PBAC

1 June 2017 - The 1 June 2017 issue of the Schedule of Pharmaceutical Benefits sees a number of new & revised listings.

The new & revised listings are:

  • Baclofen (Sintetica Baclofen Intrathecal) - new formulation
  • Everolimus (Certican) - Restriction change
  • Netupitant with palonosetron hydrochloride (Akynzeo) - new indication
  • Sacubitril with valsartan (Entresto) - new combination product

Read Summary of Changes

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Listing , Australia